Susquehanna International Group, LLP Legend Biotech Corp Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$43.55 - $59.88 $95,810 - $131,736	2,200 Added 1.49%	149,600 $7.29 Million
Q2 2024 Aug 15, 2024	SELL	$39.5 - $57.22 $3.21 Million - $4.65 Million	-81,300 Reduced 35.55%	147,400 $6.53 Million
Q1 2024 May 07, 2024	BUY	$55.06 - $69.99 $5.88 Million - $7.47 Million	106,800 Added 87.61%	228,700 $12.8 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $5.63 Million - $6.86 Million	98,400 Added 418.72%	121,900 $7.33 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $3.16 Million - $3.83 Million	-50,100 Reduced 68.07%	23,500 $1.58 Million
Q2 2023 Aug 11, 2023	BUY	$46.28 - $75.01 $1.83 Million - $2.97 Million	39,600 Added 116.47%	73,600 $5.08 Million
Q1 2023 May 16, 2023	SELL	$43.42 - $57.37 $1.36 Million - $1.8 Million	-31,400 Reduced 48.01%	34,000 $1.64 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $85,360 - $122,012	2,200 Added 3.48%	65,400 $3.26 Million
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $1.56 Million - $2.34 Million	-40,900 Reduced 39.29%	63,200 $2.58 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.44B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.